Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGM282 in Functional Constipation and Healthy Individuals
NCT02649062Phase 2Completed
- Sponsor
- NGM Biopharmaceuticals
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of aldafermin in Nonalcoholic steatohepatitis (NASH), sponsored by NGM Biopharmaceuticals. Started Dec 2015; status: completed.
02
Drugs
aldafermin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02649062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649062.